Sorted By:

Relevance


340B

PhRMA  |  From PhRMA

click here for even more information on 340B.
https://www.phrma.org/advocacy/340b

Nearly 1 in 5 Hospitals Marks Up Medicine Prices at Least 700 Percent

PhRMA  |  Press Release

Of note, average markups are likely much higher at hospitals that participate in the 340B drug pricing program because medicines acquired by 340B hospitals are purchased, on average, at a 50 percent discount.
https://www.phrma.org/nearly-1-in-5-hospitals-marks-up-medicine-prices-at-least-700-percent

PhRMA Statement on 340B PAUSE Act

PhRMA  |  Press Release

“This legislation provides Congress with a much-needed opportunity to closely evaluate 340B and ways it can be fixed to the benefit of patients.”
https://www.phrma.org/press-release/phrma-statement-on-340b-pause-act

340B Spotlight: Hospital system adds voice to comments about flawed 340B program

PhRMA  |  Blog Post

Learn more at PhRMA.org/340B.
https://catalyst.phrma.orghttps://catalyst.phrma.org/340b-spotlight-hospital-system-adds-voice-to-comments-about-flawed-340b-program

340B 101

PhRMA  |  Report

Download the deck to learn more about the 340B program.
https://www.phrma.org/report/340b-101

340B Spotlight: New pieces of legislation continue momentum to fix 340B program

PhRMA  |  Blog Post

Learn more at PhRMA.org/340B.
https://catalyst.phrma.orghttp://catalyst.phrma.org/340b-spotlight-new-pieces-of-legislation-continue-momentum-to-fix-340b-program

340B Spotlight: ICYMI – 340B hearing, new reports highlight growing need for program reform

PhRMA  |  Blog Post

To learn more about the 340B program, visit PhRMA.org/340B.
https://catalyst.phrma.org/340b-spotlight-icymi-340b-hearing-new-reports-highlight-growing-need-for-program-reform

340B Spotlight: How much money are hospitals pocketing under 340B and what are they doing with those profits?

PhRMA  |  Blog Post

Learn more about the program at PhRMA.org/340B.
https://catalyst.phrma.org/340b-spotlight-how-much-money-are-hospitals-pocketing-under-340b-and-what-are-they-doing-with-those-profits

New analysis finds 340B medicine sales hit record high in 2017 and continue to grow as a share of total drug spending

PhRMA  |  Blog Post

Read the full white paper here and learn more about 340B at PhRMA.org/340B.
https://catalyst.phrma.org/new-analysis-finds-340b-medicine-sales-hit-record-high-in-2017-and-continue-to-grow-as-a-share-of-total-drug-spending

Testimony of Lori. M Reilly - Perspectives on the 340B Drug Discount Program

PhRMA  |  Speeches & Communication

Senate Health, Education, Labor and Pensions Committee, on perspectives on the 340B drug discount program.
https://www.phrma.org/public-communication/testimony-of-lori-m-reilly-perspectives-on-the-340b-drug-discount-program

New 340B analysis: Hospitals raking in billions while uncompensated care drops by billions

PhRMA  |  Blog Post

Learn more at PhRMA.org/340B.
https://catalyst.phrma.org/new-340b-analysis-hospitals-raking-in-billions-while-uncompensated-care-drops-by-billions

GAO again recommends improvements to 340B program

PhRMA  |  Blog Post

Read the full GAO report and learn more about ways to fix 340B at PhRMA.org/340B.
https://catalyst.phrma.org/gao-again-recommends-improvements-to-340b-program

New study finds some hospitals mark up medicine prices at least 700 percent

PhRMA  |  Blog Post

Consequently, independent economists have called attention to the role of 340B hospitals in driving up health care costs across the country.
https://catalyst.phrma.org/new-study-finds-some-hospitals-mark-up-medicine-prices-at-least-700-percent

Fact Check Friday: The truth about the cost of 340B to patients

PhRMA  |  Blog Post

For more information about the 340B program, visit PhRMA.org/340B.
https://catalyst.phrma.org/fact-check-friday-the-truth-about-the-cost-of-340b-to-patients

ICYMI - Analysis finds higher outpatient drug spending at 340B hospitals

PhRMA  |  Blog Post

To learn more about 340B, visit PhRMA.org/340B.
https://catalyst.phrma.orghttps://catalyst.phrma.org/icymi-analysis-finds-higher-outpatient-drug-spending-at-340b-hospitals

PhRMA Statement on HELP ACT

PhRMA  |  Press Release

There has long been bipartisan support for fixing 340B, including recently introduced bipartisan legislation in the House, and PhRMA looks forward to working with all stakeholders to keep this momentum going.”
https://www.phrma.org/press-release/phrma-statement-on-help-act

Guest post: Developing new payment models to ensure patients have access to high-investment therapies

PhRMA  |  Blog Post

Conversations and healthy debate about i...
https://catalyst.phrma.orghttp://phrma-464546.hs-sites.com/guest-post-developing-new-payment-models-to-ensure-patients-have-access-to-high-investment-therapies

340B Spotlight: A look at 340B eligibility and charity care

PhRMA  |  Blog Post

Stricter 340B eligibility criteria are needed to address the market distorting effects of the 340B program.
https://catalyst.phrma.orghttp://catalyst.phrma.org/340b-spotlight-a-look-at-340b-eligibility-and-charity-care

340B Then & Now

PhRMA  |  Graphic

A closer look at how the 340B program has evolved since its creation in 1992.
https://www.phrma.org/graphic/340b-then-and-now

340B Spotlight: A lack of charity care among 340B hospitals

PhRMA  |  Blog Post

For more check out our chart pack or stay up-to-date on the latest 340B news with our 340B Spotlight posts.
https://catalyst.phrma.orghttp://catalyst.phrma.org/340b-spotlight-a-lack-of-charity-care-among-340b-hospitals

ICYMI: Has the 340B Program Lost Its Way?

PhRMA  |  Blog Post

To learn more about 340B follow our 340B Spotlight blog posts or sign-up for personalized email updates.
https://catalyst.phrma.orghttp://catalyst.phrma.org/icymi-has-the-340b-program-lost-its-way

340B Mega Guidance

PhRMA  |  Blog Post

Subscribe to industry alerts for issues such as 340B, access to medicines & more.
https://catalyst.phrma.orghttp://catalyst.phrma.org/340b-mega-guidance

340B Spotlight: Audit findings show importance of increased oversight of 340B program

PhRMA  |  Blog Post

Learn more about the 340B program at PhRMA.org/340B.
https://catalyst.phrma.org/340b-spotlight-audit-findings-show-importance-of-increased-oversight-of-340b-program

340B Spotlight: 340B hospitals continue to benefit from consolidation at expense of patients

PhRMA  |  Blog Post

This markup becomes even more egregious, 79 percent, if the hospital was able to acquire the drug at the 340B discounted price.
https://catalyst.phrma.org/340b-spotlight-340b-hospitals-continue-to-benefit-from-consolidation-at-expense-of-patients

340B Program in urgent need of expanded Congressional and administrative oversight, reform

PhRMA  |  Press Release

As additional evidence that the program has expanded beyond true safety net hospitals, the analysis revealed that about one-fifth of 340B hospitals provide 80 percent of all charity care delivered by 340B hospitals.
https://www.phrma.org/press-release/340b-program-in-urgent-need-of-expanded-congressional-and-administrative-oversight-reform

You have reviewed the first 25 results out of 486. Each page contains 25 results. You're on page 1.

prev 1 2 3 4 5 6 next